Selected research
Industry Research
Marevan Industry Research Report 2026
Market perspective
The global Marevan market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Marevan is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Marevan is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Marevan is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Marevan include Wuhan Shiji Pharmaceutical, Qilu Pharma, Henan Zhongjie Pharma, Zydus Pharmaceuticals, TEVA (Barr, PLIVA), Taro Pharmaceutical Industries, Taj Pharma Group, Sine Pharma (Shanghai Pharma) and Sawai Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Marevan market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Marevan Market by Company
Wuhan Shiji Pharmaceutical
Qilu Pharma
Henan Zhongjie Pharma
Zydus Pharmaceuticals
TEVA (Barr, PLIVA)
Taro Pharmaceutical Industries
Taj Pharma Group
Sine Pharma (Shanghai Pharma)
Sawai Pharmaceutical
Orion Corporation Orion Pharma
IPCA LABS
Cipla (InvaGen)
Amneal Pharma
Marevan Segment by Type
1mg/Tablet
2.5mg/Tablet
3mg/Tablet
5mg/Tablet
Others
Marevan Segment by Application
Atrial Fibrillation (AF)
Deep Vein Thrombosis (DVT)
Mechanical Heart Valves (MHV) Replacement
Pulmonary Embolism (PE)
Others
Marevan Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marevan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marevan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marevan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Marevan manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Marevan by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Marevan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg/Tablet
- 2.5mg/Tablet
- 3mg/Tablet
- 5mg/Tablet
- Others
Applications
- Atrial Fibrillation (AF)
- Deep Vein Thrombosis (DVT)
- Mechanical Heart Valves (MHV) Replacement
- Pulmonary Embolism (PE)
- Others
Companies covered
- Wuhan Shiji Pharmaceutical
- Qilu Pharma
- Henan Zhongjie Pharma
- Zydus Pharmaceuticals
- TEVA (Barr, PLIVA)
- Taro Pharmaceutical Industries
- Taj Pharma Group
- Sine Pharma (Shanghai Pharma)
- Sawai Pharmaceutical
- Orion Corporation Orion Pharma
- IPCA LABS
- Cipla (InvaGen)
- Amneal Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Marevan Market Size (2021-2032)
- 2.2.2 Global Marevan Sales (2021-2032)
- 2.2.3 Global Marevan Market Average Price (2021-2032)
- 2.3 Marevan by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1mg/Tablet
- 2.3.3 2.5mg/Tablet
- 2.3.4 3mg/Tablet
- 2.3.5 5mg/Tablet
- 2.3.6 Others
- 2.4 Marevan by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Atrial Fibrillation (AF)
- 2.4.3 Deep Vein Thrombosis (DVT)
- 2.4.4 Mechanical Heart Valves (MHV) Replacement
- 2.4.5 Pulmonary Embolism (PE)
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Marevan Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Marevan Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Marevan Revenue of Manufacturers (2021-2026)
- 3.4 Global Marevan Average Price by Manufacturers (2021-2026)
- 3.5 Global Marevan Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Marevan, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Marevan, Product Type & Application
- 3.8 Global Manufacturers of Marevan, Established Date
- 3.9 Global Marevan Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Shiji Pharmaceutical
- 4.1.1 Wuhan Shiji Pharmaceutical Company Information
- 4.1.2 Wuhan Shiji Pharmaceutical Business Overview
- 4.1.3 Wuhan Shiji Pharmaceutical Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Shiji Pharmaceutical Marevan Product Portfolio
- 4.1.5 Wuhan Shiji Pharmaceutical Recent Developments
- 4.2 Qilu Pharma
- 4.2.1 Qilu Pharma Company Information
- 4.2.2 Qilu Pharma Business Overview
- 4.2.3 Qilu Pharma Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qilu Pharma Marevan Product Portfolio
- 4.2.5 Qilu Pharma Recent Developments
- 4.3 Henan Zhongjie Pharma
- 4.3.1 Henan Zhongjie Pharma Company Information
- 4.3.2 Henan Zhongjie Pharma Business Overview
- 4.3.3 Henan Zhongjie Pharma Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Henan Zhongjie Pharma Marevan Product Portfolio
- 4.3.5 Henan Zhongjie Pharma Recent Developments
- 4.4 Zydus Pharmaceuticals
- 4.4.1 Zydus Pharmaceuticals Company Information
- 4.4.2 Zydus Pharmaceuticals Business Overview
- 4.4.3 Zydus Pharmaceuticals Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zydus Pharmaceuticals Marevan Product Portfolio
- 4.4.5 Zydus Pharmaceuticals Recent Developments
- 4.5 TEVA (Barr, PLIVA)
- 4.5.1 TEVA (Barr, PLIVA) Company Information
- 4.5.2 TEVA (Barr, PLIVA) Business Overview
- 4.5.3 TEVA (Barr, PLIVA) Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TEVA (Barr, PLIVA) Marevan Product Portfolio
- 4.5.5 TEVA (Barr, PLIVA) Recent Developments
- 4.6 Taro Pharmaceutical Industries
- 4.6.1 Taro Pharmaceutical Industries Company Information
- 4.6.2 Taro Pharmaceutical Industries Business Overview
- 4.6.3 Taro Pharmaceutical Industries Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Taro Pharmaceutical Industries Marevan Product Portfolio
- 4.6.5 Taro Pharmaceutical Industries Recent Developments
- 4.7 Taj Pharma Group
- 4.7.1 Taj Pharma Group Company Information
- 4.7.2 Taj Pharma Group Business Overview
- 4.7.3 Taj Pharma Group Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Taj Pharma Group Marevan Product Portfolio
- 4.7.5 Taj Pharma Group Recent Developments
- 4.8 Sine Pharma (Shanghai Pharma)
- 4.8.1 Sine Pharma (Shanghai Pharma) Company Information
- 4.8.2 Sine Pharma (Shanghai Pharma) Business Overview
- 4.8.3 Sine Pharma (Shanghai Pharma) Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sine Pharma (Shanghai Pharma) Marevan Product Portfolio
- 4.8.5 Sine Pharma (Shanghai Pharma) Recent Developments
- 4.9 Sawai Pharmaceutical
- 4.9.1 Sawai Pharmaceutical Company Information
- 4.9.2 Sawai Pharmaceutical Business Overview
- 4.9.3 Sawai Pharmaceutical Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sawai Pharmaceutical Marevan Product Portfolio
- 4.9.5 Sawai Pharmaceutical Recent Developments
- 4.10 Orion Corporation Orion Pharma
- 4.10.1 Orion Corporation Orion Pharma Company Information
- 4.10.2 Orion Corporation Orion Pharma Business Overview
- 4.10.3 Orion Corporation Orion Pharma Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Orion Corporation Orion Pharma Marevan Product Portfolio
- 4.10.5 Orion Corporation Orion Pharma Recent Developments
- 4.11 IPCA LABS
- 4.11.1 IPCA LABS Company Information
- 4.11.2 IPCA LABS Business Overview
- 4.11.3 IPCA LABS Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 IPCA LABS Marevan Product Portfolio
- 4.11.5 IPCA LABS Recent Developments
- 4.12 Cipla (InvaGen)
- 4.12.1 Cipla (InvaGen) Company Information
- 4.12.2 Cipla (InvaGen) Business Overview
- 4.12.3 Cipla (InvaGen) Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Cipla (InvaGen) Marevan Product Portfolio
- 4.12.5 Cipla (InvaGen) Recent Developments
- 4.13 Amneal Pharma
- 4.13.1 Amneal Pharma Company Information
- 4.13.2 Amneal Pharma Business Overview
- 4.13.3 Amneal Pharma Marevan Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Amneal Pharma Marevan Product Portfolio
- 4.13.5 Amneal Pharma Recent Developments
5 Global Marevan Market Scenario by Region
- 5.1 Global Marevan Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Marevan Sales by Region: 2021-2032
- 5.2.1 Global Marevan Sales by Region: 2021-2026
- 5.2.2 Global Marevan Sales by Region: 2027-2032
- 5.3 Global Marevan Revenue by Region: 2021-2032
- 5.3.1 Global Marevan Revenue by Region: 2021-2026
- 5.3.2 Global Marevan Revenue by Region: 2027-2032
- 5.4 North America Marevan Market Facts & Figures by Country
- 5.4.1 North America Marevan Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Marevan Sales by Country (2021-2032)
- 5.4.3 North America Marevan Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Marevan Market Facts & Figures by Country
- 5.5.1 Europe Marevan Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Marevan Sales by Country (2021-2032)
- 5.5.3 Europe Marevan Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Marevan Market Facts & Figures by Country
- 5.6.1 Asia Pacific Marevan Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Marevan Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Marevan Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Marevan Market Facts & Figures by Country
- 5.7.1 South America Marevan Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Marevan Sales by Country (2021-2032)
- 5.7.3 South America Marevan Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Marevan Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Marevan Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Marevan Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Marevan Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Marevan Sales by Type (2021-2032)
- 6.1.1 Global Marevan Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Marevan Sales Market Share by Type (2021-2032)
- 6.2 Global Marevan Revenue by Type (2021-2032)
- 6.2.1 Global Marevan Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Marevan Revenue Market Share by Type (2021-2032)
- 6.3 Global Marevan Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Marevan Sales by Application (2021-2032)
- 7.1.1 Global Marevan Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Marevan Sales Market Share by Application (2021-2032)
- 7.2 Global Marevan Revenue by Application (2021-2032)
- 7.2.1 Global Marevan Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Marevan Revenue Market Share by Application (2021-2032)
- 7.3 Global Marevan Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Marevan Value Chain Analysis
- 8.1.1 Marevan Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Marevan Production Mode & Process
- 8.2 Marevan Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Marevan Distributors
- 8.2.3 Marevan Customers
9 Global Marevan Analyzing Market Dynamics
- 9.1 Marevan Industry Trends
- 9.2 Marevan Industry Drivers
- 9.3 Marevan Industry Opportunities and Challenges
- 9.4 Marevan Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst